Search

everythinglearnresearchcommunity

for

Search:↓

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

A new compound shows promise as a topical treatment for hair loss.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib may help treat severe hair loss, but more research is needed.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.